Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
06/09/2011 | WO2011068297A1 Peroxidase variant having improved radical stability |
06/09/2011 | WO2011068261A1 Gene which enhances resistance to plant pathogens and use thereof |
06/09/2011 | WO2011068218A1 Kit and method for identification of causative bacterium of nail tinea |
06/09/2011 | WO2011068189A1 Method for detecting microorganisms belonging to mycoplasma pneumoniae and/or mycoplasma genitalium |
06/09/2011 | WO2011068176A1 Method for detecting cholangiocellular carcinoma and method of screening for prophylactic or therapeutic agent |
06/09/2011 | WO2011068166A1 Method of screening for agent for improving dry skin associated with atopic dermatitis employing activity of bleomycin hydrolase activity as measure |
06/09/2011 | WO2011068165A1 Identification and inhibition of plant-derived sugar-chain-added enzyme gene |
06/09/2011 | WO2011068159A1 Nucleic acid for production of pluripotent stem cell |
06/09/2011 | WO2011068143A1 Antibody against influenza virus subtype h5 and use thereof |
06/09/2011 | WO2011068088A1 GENE EXPRESSION ANALYSIS METHOD USING TWO DIMENSIONAL cDNA LIBRARY |
06/09/2011 | WO2011068050A1 Mutant enzyme and application thereof |
06/09/2011 | WO2011068019A1 Retrograde transport viral vector system having envelope comprising fused glycoprotein |
06/09/2011 | WO2011067971A1 Human sweet taste receptor agonist sweetness regulating substance for sweet substances |
06/09/2011 | WO2011067970A1 Sweet taste receptor expression construct, cell body expressing same, and uses therefor |
06/09/2011 | WO2011067960A1 Method for producing ethanol |
06/09/2011 | WO2011067933A1 Mybl2 peptides and vaccines containing the same |
06/09/2011 | WO2011067920A1 Imp-3 oligopeptides and vaccines including the same |
06/09/2011 | WO2011067758A2 Immunogenic fragments and multimers from streptococcus pneumoniae proteins |
06/09/2011 | WO2011067745A2 Compositions and methods for enhancing plants resistance to abiotic stress |
06/09/2011 | WO2011067712A1 Expression cassettes for embryo-specific expression in plants |
06/09/2011 | WO2011067630A1 Method and kit for dna extraction from vitis vinifera l. and for amplification and detection of grapevine varieties or cultivars in musts or wines |
06/09/2011 | WO2011067553A1 Cells for the production of biotin - tagged viral vectors or proteins |
06/09/2011 | WO2011067420A1 Arf6 as a new target for treating alzheimer's disease |
06/09/2011 | WO2011066721A1 Antl-igf-ir antibodies and uses thereof |
06/09/2011 | WO2011066711A1 Specific antigen of clonorchis sinensis and uses thereof |
06/09/2011 | WO2011066681A1 Human high metastatic nasopharyngeal carcinoma cell strain s18 stably expressing tet-off advanced, construction method and uses thereof |
06/09/2011 | WO2011066651A1 Snalp formulations containing antioxidants |
06/09/2011 | WO2011066615A1 Methods and compositions for increasing titer of recombinant porcine adenovirus-3 vectors |
06/09/2011 | WO2011046983A3 Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro |
06/09/2011 | WO2011041886A8 Vaccines comprising heat-sensitive transgenes |
06/09/2011 | WO2011028533A3 Methods for detecting dna methylation using encoded particles |
06/09/2011 | WO2011024065A8 A method of developing stress tolerant plants exhibiting self-glucogenic properties for use in bioethanol production from lignocellulosic biomass |
06/09/2011 | WO2011017696A3 Methods relating to aromatase inhibitor pharmacogenetics |
06/09/2011 | WO2010138806A3 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene |
06/09/2011 | WO2010117804A3 Mostly natural dna sequencing by synthesis |
06/09/2011 | WO2010088565A8 Nucleic acid delivery using modified chitosans |
06/09/2011 | WO2010060186A8 Antibodies that specifically block the biological activity of a tumor antigen |
06/09/2011 | WO2009126808A3 Transgenic animal model of cancer and methods of use |
06/09/2011 | WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
06/09/2011 | US20110138502 Transgenic plants expressing civps or intein modified proteins and related method |
06/09/2011 | US20110138501 Plants with altered root architecture, related constructs and methods involving genes encoding protein phophatase 2c (pp2c) polypeptides and homologs thereof |
06/09/2011 | US20110138500 Polynucleotides and polypeptides encoded therefrom and methods of using same for increasing biomass in plants and plants generated thereby |
06/09/2011 | US20110138498 Modulation of receptor-like kinases for promotion of plant growth |
06/09/2011 | US20110138497 Non-Diffusing Plant Virus Vector |
06/09/2011 | US20110138496 Polypeptide for improving tolerance to iron deficiency in plants, and use thereof |
06/09/2011 | US20110138495 Methods and Compositions for Expressing Proteins In Plants |
06/09/2011 | US20110138494 Pea line 08240772 |
06/09/2011 | US20110138492 Transgenic sugar beet plants |
06/09/2011 | US20110138491 Compositions and Method for Epigenetic Modification of Nucleic Acid Sequences in Vivo |
06/09/2011 | US20110138490 Desaturase and method for the production of polyunsaturated fatty acids in transgenic organisms |
06/09/2011 | US20110137020 Method and Device for Purifying Nucleic Acids |
06/09/2011 | US20110137014 Super humanized antibodies |
06/09/2011 | US20110137013 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
06/09/2011 | US20110137011 Hyperglycosylated human coagulation factor ix |
06/09/2011 | US20110137002 Method for the enzyme-catalysed hydrolysis of polyacrylic acid esters, and esterases used therefor |
06/09/2011 | US20110136922 Activation induced deaminase (aid) |
06/09/2011 | US20110136907 Perhydrolase providing improved peracid stability |
06/09/2011 | US20110136896 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof |
06/09/2011 | US20110136894 Shortened Alk1 Regulatory Fragment |
06/09/2011 | US20110136891 Nucleic acid molecules and collections thereof, their application and Identification |
06/09/2011 | US20110136890 Treatment of fibrotic conditions |
06/09/2011 | US20110136753 Glycosylated indolecarbazoles, method for obtaining same and uses thereof |
06/09/2011 | US20110136746 Kallikrein-Binding "Kunitz Domain" Proteins and Analogues Thereof |
06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
06/09/2011 | US20110136697 Methods for synthesis of encoded libraries |
06/09/2011 | US20110136695 Universal libraries for immunoglobulin |
06/09/2011 | US20110136689 Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian Cells |
06/09/2011 | US20110136687 METHOD FOR DETERMINING THE DEGREE OF METHYLATION OF DEFINED CYTOSINES IN GENOMIC DNA IN THE SEQUENCE CONTEXT OF 5'-CpG-3' |
06/09/2011 | US20110136678 Methodology for analysis of sequence variations within the hcv ns3/4a genomic region |
06/09/2011 | US20110136237 Site-specific recombination systems for use in eukaryotic cells |
06/09/2011 | US20110136236 Genetically modified eukaryotic cells |
06/09/2011 | US20110136235 MK167 Mini-Promoters |
06/09/2011 | US20110136233 Nucleic acid compounds for inhibiting plk1 gene expression and uses thereof |
06/09/2011 | US20110136232 Anti-pyk2 antibodies |
06/09/2011 | US20110136227 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
06/09/2011 | US20110136224 Mda-7 proteins and methods of use thereof |
06/09/2011 | US20110136221 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities |
06/09/2011 | US20110136207 Mutated Nucleotide Sequences of Batroxobin, Mutated Alpha Factor Secretion Signal Sequence and Processes for Preparing Batroxobin Using the Same |
06/09/2011 | US20110136206 Alpha-amylase variant with altered properties |
06/09/2011 | US20110136205 Alpha-amylase variants with altered properties |
06/09/2011 | US20110136204 Extract of e. coli cells having mutation in ribosomal protein s12, and method for producing protein in cell-free system using the extract |
06/09/2011 | US20110136202 Eukaryotic amadoriase, gene and recombinant dna for the eukaryotic amadoriase, and process for production of the eukaryotic amadoriase |
06/09/2011 | US20110136195 Genetically-engineered yeast and methods of making and using |
06/09/2011 | US20110136192 Flux to acetolactate-derived products in lactic acid bacteria |
06/09/2011 | US20110136184 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
06/09/2011 | US20110136183 Method for producing alpha-1, 6-branched alpha-1, 4-glucans from sucrose |
06/09/2011 | US20110136173 Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment |
06/09/2011 | US20110136172 Mammalian cytokines; related reagents |
06/09/2011 | US20110136170 Method and kit for purification of recombinant proteins using a self-cleaving protein intein |
06/09/2011 | US20110136169 Expression system compositions and methods |
06/09/2011 | US20110136148 Monoclonal Antibodies Against GMF-B Antigens, and Uses Therefor |
06/09/2011 | US20110136145 Methods for promoting fusion and reprogramming of somatic cells |
06/09/2011 | US20110136128 Reporter assay screens for protein targets in saccharomyces cerevisiae |
06/09/2011 | US20110136119 AIMP2-DX2 Gene and its Uses |
06/09/2011 | US20110136114 Neural regenerating cells with alterations in dna methylation |
06/09/2011 | US20110136110 Method for the production of medium-chain sophorolipids |
06/09/2011 | US20110136108 XBP1(S) Protein Acting as an Adipocyte Differentiation Marker Having a Facility to Regulate Differentiation into Adipocytes, and an Application Therefor |
06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
06/09/2011 | US20110135710 Methods and Compositions for the Inhibition of Gene Expression |
06/09/2011 | US20110135688 Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors |